Senior Research Fellow, Gastrointestinal Group Lead
E: eleonoraf@nswcc.org.au
Research
Dr Eleonora Feletto leads the Gastrointestinal Cancers Policy and Evaluation Stream at the Daffodil Centre. She completed a PhD in the Pharmacy Faculty at the University of Sydney in 2010. Her research interests include the areas of cancer control, environmental risk factors of cancer, the implementation of health services in practice and the use of alternative channels to build a sustainable health care system. Eleonora’s current work at the Daffodil Centre focuses on prevention and early detection of colorectal and liver cancer in Australia..
Qualifications
- Doctor of Philosophy, Faculty of Pharmacy, The University of Sydney
- Bachelors of Business/Bachelor of Arts (in International Studies), University of Technology, Sydney
Selected key publications
Feletto E, Kohar A, Mizrahi D, Grogan P, Steinberg J, Hughes C, Watson WL, Canfell K, Yu XQ. An ecological study of obesity-related cancer incidence trends in Australia from 1983 to 2017. The Lancet Regional Health-Western Pacific. 2022 Dec 1;29:100575.
Luo Q, Lew J-B, Steinberg J, Worthington J, Yu XQ, Caruana M, Soerjomataram I, Bray F, Lawrance S, Arcorace M, O’Connell DL, Canfell K, Feletto E. Trends in colon and rectal cancer mortality in Australia from 1972-2015 and associated projections to 2040. Sci Rep. 2022;10.1038/s41598-022-07797-x.
Lew JB, Feletto E, Worthington J, Roder D, Canuto K, Miller C, D’Onise K, Canfell K. The potential for tailored screening to reduce bowel cancer mortality for Aboriginal and Torres Strait Islander peoples in Australia: modelling study. Journal of Cancer Policy. 2022 Feb 8:100325.
de Jonge L, Worthington J, van Wifferen F, Iragorri N, Peterse EFP, Lew J-B, Greuter MJE, Smith HA, Feletto E, Yong JHE, Canfell K, Coupe VMH, Lansdorp-Vogelaar I. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study Lancet Gastroenterology & Hepatology. 2021. 3 Feb.
Shi JF, Cao M, Bai FZ, Lei L, Peng J, Feletto E, Canfell K, Qu C, Chen W. Is it possible to halve the incidence of liver cancer in China by 2050? Int J Cancer. 2020 doi: 10.1002/ijc.33313
Worthington J, Feletto E, Lew JB, Broun K, Durkin S, Wakefield M, Grogan P, Harper T, Canfell K. Evaluating health benefits and cost-effectiveness of a mass-media campaign for improving participation in the National Bowel Cancer Screening Program in Australia. Public Health. 2020 179: 90-99
Feletto E, Yu XQ, Lew JB, St John DJB, Jenkins M, Macrae FM, Mahady SE, Canfell K Trends in colon and rectal cancer incidence in Australia from 1982 to 2014: Analysis of data on over 375,000 cases Cancer Epidemiology, Biomarkers and Prevention 2018